Danielle Snider1, Pamela J Weathers2. 1. Department of Biology and Biotechnology, Worcester Polytechnic Institute, Worcester, MA, 01609, USA. Electronic address: dasnider@wpi.edu. 2. Department of Biology and Biotechnology, Worcester Polytechnic Institute, Worcester, MA, 01609, USA. Electronic address: weathers@wpi.edu.
Abstract
ETHNOPHARMACOLOGICAL RELEVANCE: Artemisia annua has a long history of use in Southeast Asia where it was used to treat "fever", and A. afra has a similar history in southern Africa. Since their discovery, A. annua use, in particular, has expanded globally with millions of people using the plant in therapeutic tea infusions, mainly to treat malaria. AIM OF THE STUDY: In this study, we used in vitro studies to query if and how A. annua and A. afra tea infusions being used across the globe affect asexual Plasmodium falciparum parasites, and their sexual gametocytes. MATERIALS AND METHODS: P. falciparumstrain NF54 was grown in vitro, synchronized, and induced to form gametocytes using N-acetylglucosamine. Cultures during asexual, early, and late stage gametocytogenesis were treated with artemisinin, methylene blue, and A. annua and A. afra tea infusions (5 g DW/L) using cultivars that contained 0-283 μM artemisinin. Asexual parasitemia and gametocytemia were analyzed microscopically. Gametocyte morphology also was scored. Markers of early (PfGEXP5) and late stage (Pfs25) gametocyte gene expression also were measured using RT-qPCR. RESULTS: Both A. annua and A. afra tea infusions reduced gametocytemia in vitro, and the effect was mainly artemisinin dependent. Expression levels of both marker genes were reduced and also occurred with the effect mainly attributed to artemisinin content of four tested Artemisia cultivars. Tea infusions of both species also inhibited asexual parasitemia and although mainly artemisinin dependent, there was a weak antiparasitic effect from artemisinin-deficient A. afra. CONCLUSIONS: These results showed that A. annua and to a lesser extent, A. afra, inhibited parasitemia and gametocytemia in vitro.
ETHNOPHARMACOLOGICAL RELEVANCE: Artemisia annua has a long history of use in Southeast Asia where it was used to treat "fever", and A. afra has a similar history in southern Africa. Since their discovery, A. annua use, in particular, has expanded globally with millions of people using the plant in therapeutic tea infusions, mainly to treat malaria. AIM OF THE STUDY: In this study, we used in vitro studies to query if and how A. annua and A. afra tea infusions being used across the globe affect asexual Plasmodium falciparum parasites, and their sexual gametocytes. MATERIALS AND METHODS: P. falciparumstrain NF54 was grown in vitro, synchronized, and induced to form gametocytes using N-acetylglucosamine. Cultures during asexual, early, and late stage gametocytogenesis were treated with artemisinin, methylene blue, and A. annua and A. afra tea infusions (5 g DW/L) using cultivars that contained 0-283 μM artemisinin. Asexual parasitemia and gametocytemia were analyzed microscopically. Gametocyte morphology also was scored. Markers of early (PfGEXP5) and late stage (Pfs25) gametocyte gene expression also were measured using RT-qPCR. RESULTS: Both A. annua and A. afra tea infusions reduced gametocytemia in vitro, and the effect was mainly artemisinin dependent. Expression levels of both marker genes were reduced and also occurred with the effect mainly attributed to artemisinin content of four tested Artemisia cultivars. Tea infusions of both species also inhibited asexual parasitemia and although mainly artemisinin dependent, there was a weak antiparasitic effect from artemisinin-deficient A. afra. CONCLUSIONS: These results showed that A. annua and to a lesser extent, A. afra, inhibited parasitemia and gametocytemia in vitro.
Authors: Luiz Francisco Rocha e Silva; Pedro Melillo de Magalhães; Mônica Regina Farias Costa; Maria das Graças Costa Alecrim; Francisco Célio Maia Chaves; Ari de Freitas Hidalgo; Adrian Martin Pohlit; Pedro Paulo Ribeiro Vieira Journal: Mem Inst Oswaldo Cruz Date: 2012-11 Impact factor: 2.743
Authors: J Teun Bousema; Petra Schneider; Louis C Gouagna; Chris J Drakeley; Alma Tostmann; Rein Houben; John I Githure; Rosalynn Ord; Colin J Sutherland; Sabah A Omar; Robert W Sauerwein Journal: J Infect Dis Date: 2006-03-15 Impact factor: 5.226
Authors: Tomasz Czechowski; Mauro A Rinaldi; Mufuliat Toyin Famodimu; Maria Van Veelen; Tony R Larson; Thilo Winzer; Deborah A Rathbone; David Harvey; Paul Horrocks; Ian A Graham Journal: Front Plant Sci Date: 2019-07-30 Impact factor: 5.753
Authors: Tsin W Yeo; Daniel A Lampah; Retno Gitawati; Emiliana Tjitra; Enny Kenangalem; Yvette R McNeil; Christabelle J Darcy; Donald L Granger; J Brice Weinberg; Bert K Lopansri; Ric N Price; Stephen B Duffull; David S Celermajer; Nicholas M Anstey Journal: J Exp Med Date: 2007-10-22 Impact factor: 14.307
Authors: John O Suberu; Alexander P Gorka; Lauren Jacobs; Paul D Roepe; Neil Sullivan; Guy C Barker; Alexei A Lapkin Journal: PLoS One Date: 2013-11-14 Impact factor: 3.240